
Call for teenage volunteers from across Greater Manchester to be part of COVID-19 vaccine study
A COVID-19 vaccine study, analysing third dose booster options for 12 to 15-year-olds, is open at Royal Manchester Children’s Hospital.
Read moreA COVID-19 vaccine study, analysing third dose booster options for 12 to 15-year-olds, is open at Royal Manchester Children’s Hospital.
Read moreThe outstanding commitment to critical care research by a children’s intensive care research team at Manchester University NHS Foundation Trust (MFT) has received national recognition.
Read moreSeven Manchester University NHS Foundation Trust (MFT) Consultants, are among 16 outstanding individuals announced by Manchester Academic Health Science Centre (MAHSC).
Read moreIn her blog Gabby Addison shares her student nurse experiences at the NIHR Manchester Clinical Research Facility, and how she is proud to be back as a Clinical Research Nurse.
Read moreChildren in the UK will be able to receive Palforzia – a life-changing oral treatment for peanut allergies – as NHS standard of care following approval for use by NICE.
Read moreThe NHS has struck a deal for a life-saving treatment that will offer babies and young children with a rare and life-limiting genetic disease the prospect of a normal life.
Read moreA Royal Manchester Children’s Hospital patient is the first young person in the world to participate in a study researching a new drug to treat itching caused by kidney failure.
Read moreChildren with adrenal insufficiency have a higher risk of dying than those with other lifelong conditions, according to research by The University of Manchester and MFT scientists.
Read more